Curaleaf Holdings, Inc. Stock Canadian Securities Exchange
Equities
CURA
CA23126M1023
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -10.77% | -10.46% |
May. 24 | Curaleaf "Disagrees" With Miller Amendment to 2018 Farm Bill in U.S. | MT |
May. 22 | Curaleaf Holdings, Inc. Celebrates Miami North Biscayne Dispensary Opening | CI |
Sales 2024 * | 1.41B 1.92B | Sales 2025 * | 1.54B 2.11B | Capitalization | 3.43B 4.68B |
---|---|---|---|---|---|
Net income 2024 * | -157M -214M | Net income 2025 * | -55M -75.09M | EV / Sales 2024 * | 2.8 x |
Net Debt 2024 * | 523M 714M | Net Debt 2025 * | 728M 994M | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
-27.4
x | P/E ratio 2025 * |
-48.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.1% |
Latest transcript on Curaleaf Holdings, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 29 M€ | -1.95% | - | |
0.00% | 146 M€ | -2.63% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.45% | 1.83B | |
+173.02% | 90.77M |
- Stock Market
- Equities
- CURA Stock
- CURA Stock